Upgrade to SI Premium - Free Trial

STERIS (STE) PT Raised to $254 at Needham & Company

August 10, 2021 12:05 PM
Needham & Company analyst Mike Matson raised the price target on STERIS (NYSE: STE) to $254.00 (from $233.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles